InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Wasman Jane, Director. Director active across 3 companies, notably RIGEL PHARMACEUTICALS INC. In total, 5 disclosures have been logged. The latest transaction was disclosed on 20 May 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations5 total
025,000 shares0
Common Stock
SEC:0001140361-22-020307:0·
01,900 shares0
Common Stock
SEC:0001104659-22-010400·
01,900 shares0
Common Stock
SEC:0001104659-22-010400:0·
025,000 shares0
Common Stock
SEC:0001179110-21-005769·
025,000 shares0
Common Stock
SEC:0001179110-21-005769:0·
5 of 5 declarations
About Wasman Jane
Jane Wasman is a Board Member at Rigel Pharmaceuticals Inc and Sellas Life Sciences Group, Inc. She plays a key role in shaping the company's strategies, bringing her expertise in the pharmaceutical sector. Her commitment to innovation and research is crucial for the development of new treatments.
